InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-25.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Wasman Jane, Director. Director active across 4 companies, notably RIGEL PHARMACEUTICALS INC. In total, 12 disclosures have been logged. History available since 19 May 2021. The latest transaction was filed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
12,500 shares0Common StockSEC:0001104659-25-003498:0
25,000 shares0Common StockSEC:0000905148-24-001656:0
6,000 shares0Common StockSEC:0001104659-24-006397:0
25,000 shares0Common StockSEC:0001140361-23-034288:0
2,500 shares0Common StockSEC:0001104659-23-010629:0
22,321 shares0Common StockSEC:0001368148-23-000017:0
12,820 shares0Common StockSEC:0001368148-22-000131:0
25,000 shares0Common StockSEC:0001140361-22-020307:0
1,900 shares0Common StockSEC:0001104659-22-010400:0
1,900 shares0Common StockSEC:0001104659-22-010400
25,000 shares0Common StockSEC:0001179110-21-005769
25,000 shares0Common StockSEC:0001179110-21-005769:0
12 of 12 declarations
About Wasman Jane
Jane Wasman is a Board Member at Rigel Pharmaceuticals Inc and Sellas Life Sciences Group, Inc. She plays a key role in shaping the company's strategies, bringing her expertise in the pharmaceutical sector. Her commitment to innovation and research is crucial for the development of new treatments.
